We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$303M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.2M
3
IYR icon
iShares US Real Estate ETF
IYR
+$17.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.4M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$26.8M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.6M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$24.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$24M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.2M

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRS icon
3026
Coherus Oncology
CHRS
$196M
$2K ﹤0.01%
+76
New +$2.07K
CIG.C icon
3027
CEMIG Ordinary Shares
CIG.C
$8.95B
$2K ﹤0.01%
1,012
-24
-2% -$39
CLFD icon
3028
Clearfield
CLFD
$374M
$2K ﹤0.01%
100
-511
-84% -$9.45K
CLRB icon
3029
Cellectar Biosciences
CLRB
$20.5M
– –
0
– –
CLWT icon
3030
Euro Tech Holdings
CLWT
$11.8M
$2K ﹤0.01%
2,741
+262
+11% +$214
PRHI
3031
Presurance Holdings
PRHI
$17.2M
$2K ﹤0.01%
33
-67
-67% -$3.64K
COHU icon
3032
Cohu
COHU
$2.5B
$2K ﹤0.01%
145
-1,253
-90% -$13.8K
CSPI icon
3033
CSP Inc
CSPI
$82.1M
$2K ﹤0.01%
306
-1,462
-83% -$6.61K
CTMX icon
3034
CytomX Therapeutics
CTMX
$754M
$2K ﹤0.01%
102
-36
-26% -$436
CVBF icon
3035
CVB Financial
CVBF
$3.99B
$2K ﹤0.01%
100
-805
-89% -$13.7K
CVGI icon
3036
Commercial Vehicle Group
CVGI
$147M
$2K ﹤0.01%
+300
New +$1.48K
BGMSP
3037
DELISTED
Bio Green Med Solution Inc Preferred Stock
BGMSP
$2K ﹤0.01%
333
-45
-12% -$308
CYBR
3038
DELISTED
CyberArk
CYBR
$2K ﹤0.01%
39
-61
-61% -$3.25K
BGMS
3039
Bio Green Med Solution Inc
BGMS
$5.24M
– –
0
– –
CYRX icon
3040
CryoPort
CYRX
$762M
$2K ﹤0.01%
1,084
-100
-8% -$197
CYTK icon
3041
Cytokinetics
CYTK
$10.4B
$2K ﹤0.01%
223
-493
-69% -$5.15K
DAIO icon
3042
Data I/O
DAIO
$30.6M
$2K ﹤0.01%
621
-282
-31% -$924
DARE icon
3043
Dare Bioscience
DARE
$21M
$2K ﹤0.01%
19
-4
-17% -$896
DBEM icon
3044
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$108M
$2K ﹤0.01%
+84
New +$1.66K
DEEP icon
3045
Acquirers Small and Micro Deep Value ETF
DEEP
$28.6M
$2K ﹤0.01%
+93
New +$2.28K
DIOD icon
3046
Diodes
DIOD
$4.84B
$2K ﹤0.01%
+100
New +$1.95K
DPST icon
3047
Direxion Daily Regional Banks Bull 3X ETF
DPST
$391M
$2K ﹤0.01%
+3
New +$1.85K
ECC
3048
Eagle Point Credit Company
ECC
$513M
$2K ﹤0.01%
141
-124
-47% -$2.12K
ENOR icon
3049
iShares MSCI Norway ETF
ENOR
$99.5M
$2K ﹤0.01%
100
-100
-50% -$2.04K
ERTH icon
3050
Invesco MSCI Sustainable Future ETF
ERTH
$138M
$2K ﹤0.01%
+53
New +$1.69K
120 121
122
123 124

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.